Medical treatment for children with severe systemic juvenile idiopathic arthritis is unsatisfactory at present, and affected patients suffer from significant morbidity throughout their lives. Research into the pathogenesis of this disease should allow for the identification of new molecular targets and the development of improved therapies for this serious form of childhood arthritis.